"Abbot" Efinin C-reactive protein assay set - Taiwan Registration d526dc8c5d3daf6ee6724e5f83822523
Access comprehensive regulatory information for "Abbot" Efinin C-reactive protein assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d526dc8c5d3daf6ee6724e5f83822523 and manufactured by ABBOTT DIAGNOSTICS TECHNOLOGIES AS. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used for the quantitative detection of C-reactive protein (CRP) in human whole blood, serum and plasma.
A Clinical Chemistry and Clinical Toxicology;; C Immunology and Microbiology
A.1660 Grade Material (Analysis Material Non-Analysis);; C.5270 Canti-protein immunotry system
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Jan 08, 2021
Jan 08, 2026

